Alpha-1-antitrypsin (AAT) is an abundant glycoprotein in the plasma, is synthetized in the liver and acts as an inhibitor of serine proteases like neutrophil elastase (HNE). Mutations in the AAT gene generally lead to reduced AAT levels in the plasma (AAT deficiency, AATD), thus diagnostic protocols are based primarily on AAT plasma quantification. The unbalance between AAT and the target proteases in the lungs predisposes to emphysema. AAT specifically binds HNE via its flexible and solvent exposed reactive center loop (RCL) and, upon cleavage, undergoes a conformational change that traps the protease in a covalent irreversible complex. Our aim was to identify amino acid variants in the RCL domain that impair anti-elastase activity. We considered AAT variants arising from all possible amino acid changes due to single nucleotide variations, excluding residues with high similarity. Interestingly, a subset of these variants is reported in the gnomAD database. The selected variants were expressed in HEK293T cells along with wild-type AAT, the common polymerogenic mutant Z (E342K) and the previously characterized dysfunctional Iners (G349R). We quantified AAT in conditioned media by ELISA and by non-denaturing PAGE analysis. In contrast with the Z AAT mutant, which is conformationally altered and preferentially accumulates in the endoplasmic reticulum as polymeric chains, all the selected RCL variants were secreted normally in the native monomeric conformation. Then anti-elastase activity of RCL variants was investigated by three independent assays: (1) analysis of HNE-AAT complexes by SDS-PAGE analysis; (2) binding to elastase adsorbed on multi-well plates, (3) inhibition of HNE activity on chromogenic substrates. Our results identified five fully dysfunctional AAT variants and four ones with diminished anti-elastase activity. Notably, due to their normal secretion, such variants would not be identified by AATD diagnostic protocols.

Functional characterization of amino acid variants of the reactive-center-loop of alpha-1-antitrypsin

Emna Ben Khlifa;Mattia Bignotti;Giulia Bartoli;Andrea Denardo;Annamaria Fra
2022-01-01

Abstract

Alpha-1-antitrypsin (AAT) is an abundant glycoprotein in the plasma, is synthetized in the liver and acts as an inhibitor of serine proteases like neutrophil elastase (HNE). Mutations in the AAT gene generally lead to reduced AAT levels in the plasma (AAT deficiency, AATD), thus diagnostic protocols are based primarily on AAT plasma quantification. The unbalance between AAT and the target proteases in the lungs predisposes to emphysema. AAT specifically binds HNE via its flexible and solvent exposed reactive center loop (RCL) and, upon cleavage, undergoes a conformational change that traps the protease in a covalent irreversible complex. Our aim was to identify amino acid variants in the RCL domain that impair anti-elastase activity. We considered AAT variants arising from all possible amino acid changes due to single nucleotide variations, excluding residues with high similarity. Interestingly, a subset of these variants is reported in the gnomAD database. The selected variants were expressed in HEK293T cells along with wild-type AAT, the common polymerogenic mutant Z (E342K) and the previously characterized dysfunctional Iners (G349R). We quantified AAT in conditioned media by ELISA and by non-denaturing PAGE analysis. In contrast with the Z AAT mutant, which is conformationally altered and preferentially accumulates in the endoplasmic reticulum as polymeric chains, all the selected RCL variants were secreted normally in the native monomeric conformation. Then anti-elastase activity of RCL variants was investigated by three independent assays: (1) analysis of HNE-AAT complexes by SDS-PAGE analysis; (2) binding to elastase adsorbed on multi-well plates, (3) inhibition of HNE activity on chromogenic substrates. Our results identified five fully dysfunctional AAT variants and four ones with diminished anti-elastase activity. Notably, due to their normal secretion, such variants would not be identified by AATD diagnostic protocols.
2022
File in questo prodotto:
File Dimensione Formato  
Abstract_ABCD_ Ben Khlifa et al.pdf

solo utenti autorizzati

Descrizione: Abstract a convegno
Tipologia: Abstract
Licenza: DRM non definito
Dimensione 105.49 kB
Formato Adobe PDF
105.49 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11379/555996
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact